Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives
- PMID: 18615225
- PMCID: PMC3988678
- DOI: 10.1007/BF02982704
Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives
Abstract
Sarcopenia is a loss of muscle protein mass and loss of muscle function. It occurs with increasing age, being a major component in the development of frailty. Current knowledge on its assessment, etiology, pathogenesis, consequences and future perspectives are reported in the present review. On-going and future clinical trials on sarcopenia may radically change our preventive and therapeutic approaches of mobility disability in older people.
Figures
References
-
- Landi F, et al. Body mass index and mortality among older people living in the community. J Am Geriatr Soc. 1999;47(9):1072–6. - PubMed
-
- Rosenberg Summary comments. Am J Clin Nutr. 1989;(50):1231–3.
-
- Schwartz RS. Sarcopenia and physical performance in old age: introduction. Muscle Nerve Suppl. 1997;5:S10–2. - PubMed
-
- Hughes VA, et al. Longitudinal changes in body composition in older men and women: role of body weight change and physical activity. Am J Clin Nutr. 2002;76(2):473–81. - PubMed
-
- Vandervoort AA. Aging of the human neuromuscular system. Muscle Nerve. 2002;25(1):17–25. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical